🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06618911
Recruiting Not applicable

Evaluation of the Efficacy of Electroacupuncture in the Treatment of Functional Dyspepsia

NCT06618911 · tracked via the Priya Life Science China tracker
Sponsor
Yi Liang
Phase
Not applicable
Started
2025-04-13
Last updated
2025-08-29

Condition(s) studied

Functional Dyspepsia

Investigational drug(s) / intervention(s)

5 Hz electroacupunctureSham electroacupuncture100 Hz electroacupuncture

5 Hz electroacupuncture: Intervention Description: The intervention in this study involves the use of electroacupuncture (EA), a combination of traditional acupuncture and electrical stimulation. Acupoints Selection: Electroacupuncture will be performed at specific acupoints associated with the stomach and digestive system. The local acupoints chosen are Liangmen (ST21) and Tianshu (ST25), while the distal acupoints are Zusanli (ST36) and Xiajuxu (ST39). This selection is based on Traditional Chinese Medicine (TCM) principles for treating functional dyspepsia. Frequency: 5 Hz

Sham electroacupuncture: Participants will receive sham electroacupuncture at the same acupoints: Liangmen (ST21), Tianshu (ST25), Zusanli (ST36), and Xiajuxu (ST39). Non-penetrating needles will touch the skin but will not induce \"deqi.\" A sham electroacupuncture device (no actual current) will be used, and treatment will last 30 minutes per session. Participants will receive 3 sessions per week for 4 weeks (total: 12 sessions). This arm serves as a placebo control to evaluate the true effect of electroacupuncture.

100 Hz electroacupuncture: Intervention Description: The intervention in this study involves the use of electroacupuncture (EA), a combination of traditional acupuncture and electrical stimulation. Acupoints Selection: Electroacupuncture will be performed at specific acupoints associated with the stomach and digestive system. The local acupoints chosen are Liangmen (ST21) and Tianshu (ST25), while the distal acupoints are Zusanli (ST36) and Xiajuxu (ST39). This selection is based on Traditional Chinese Medicine (TCM) principles for treating functional dyspepsia. Frequency: 100 Hz

Study summary

Brief Summary Template for the Study:

The goal of this clinical trial is to evaluate whether electroacupuncture can treat functional dyspepsia (FD) in adult participants aged 18 to 65 years, including both males and females, who have been diagnosed with functional dyspepsia based on the Rome IV criteria. The main questions it aims to answer are:

* Does 5 Hz electroacupuncture improve symptoms in functional dyspepsia patients?
* Does 100 Hz electroacupuncture improve symptoms in functional dyspepsia patients?
* Are there differences in the efficacy between 5 Hz and 100 Hz electroacupuncture in treating functional dyspepsia and its subtypes (PDS and EPS)?

Researchers will compare the effects of 5 Hz electroacupuncture, 100 Hz electroacupuncture, and sham electroacupuncture to determine which approach provides more significant symptom relief and whether different frequencies have varying impacts on FD subtypes.

Participants will:

* Receive electroacupuncture treatment at specific acupoints (such as Liangmen, Tianshu, Zusanli, and Xiajuxu) for 30-minute sessions, 3 times a week for 4 weeks.
* Be randomly assigned to one of the following groups: 5 Hz electroacupuncture, 100 Hz electroacupuncture, or sham electroacupuncture (control).
* Have their functional dyspepsia symptoms, quality of life, and any adverse effects monitored and evaluated throughout the study.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with functional dyspepsia based on Rome IV diagnostic criteria. * Aged 18 to 80 years, inclusive, with no gender restrictions. * Normal endoscopy results within the past year, showing no structural explanation for symptoms. * No acupuncture treatment in the last month. * Not participating in any other clinical trials in the past 2 months. * Able to understand and provide informed consent. Exclusion Criteria: * Presence of serious or malignant diseases (e.g., cirrhosis, heart failure, gastrointestinal tumors) that could explain dyspepsia symptoms. * Positive for Helicobacter pylori infection based on C-13 urea breath test or gastric biopsy. * History of gastrointestinal surgery (excluding laparoscopic and other minimally invasive surgeries). * Recent use (within 2 weeks) of medications affecting dyspepsia, including prokinetics, proton pump inhibitors, antacids, or antidepressants. * Presence of severe mental or physical conditions, such as dementia or illiteracy, that could interfere with study participation. * Severe coagulation disorders. * Substance abuse or alcohol dependence. * Pregnant or breastfeeding women.

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
The Third Affiliated Hospital of Zhejiang Chinese Medicinal University Hangzhou None Selected Recruiting
Hangzhou First People's Hospital Hangzhou Zhejiang Recruiting
Sir Run Run Shaw Hospital, affiliated with the Zhejiang University School of Medicine Hangzhou Zhejiang Recruiting
The First Affiliated Hospital of Zhejiang Chinese Medical University Hangzhou Zhejiang Recruiting

More Yi Liang trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06618911 on ClinicalTrials.gov ↗ ← All trials in China